Tuesday, May 08, 2018 9:24:09 PM
Pozi won’t get there overnight but it’s nice to know it’s potential in say 7 to 10 years. It first needs to get approved in NSCLC (in the US that’s about 2 yrs away). It will also need to start a basket study in those 20 cancer indications that Dr. Heymach talked about in the video (expected to start this year) and get approval for that. He felt confident that will happen giving examples of other TKIs targeting mutations successfully in other cancers e.g. B-RAF and ALK, etc. SPPI will need to run these studies, or probably more correct, its licensing partners will, in the EU and Japan. With every sign that becomes more of a certainty, the share price will rise. If you are not certain now, September’s WCLC when more mature data will be released will add so much more certainty. If you believe the MDA data released in April showing the 1st 11 EGFR patients still not reaching medium PFS after 6.6 months where 4 to 6 months is a homerun then the share price of Spectrum now is at fire sale prices. This share price is a godsend to small investors to get multiples on their investment but who have to take chances (risk of trial failing?) in order to stay ahead of the big boys who can instantaneously jump on the share price with any good news. A small investor who jumps in on good news (in Sept?) after the big boys jump in will make money but perhaps just make a half a multiple or so. I guess it depends on your level of risk taking on how you proceed. Another factor that will affect the sales projection is how long will mPFS be. Right now it’s at 6.6 months, say it settles at 8 months, that’s only 2/3 of a year so you will need to decrease that sales projection by a third, if it’s over a year you’ll need to increase accordingly. Licensing deals will weigh in on the share price as well as the licensing agreement with MDA where they got LOTS of incentive to mine their trove of data
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM